Figure 2 outlines the timing of BRCA1 and 2 identification, start of oncogenetic clinic, BRCA register, DNA tests, and BC diagnoses of the current study as well as for the additional sensitivity analysis. This evidence concerns the gene BRCA1 and breast cancer.